2024-03-012025-02-282025-02-28false14643092DR KARINA LTD2025-08-27falseiso4217:GBPxbrli:pure146430922024-02-29146430922025-02-28146430922024-03-012025-02-28146430922023-02-05146430922024-02-29146430922023-02-062024-02-2914643092bus:SmallEntities2024-03-012025-02-2814643092bus:AuditExempt-NoAccountantsReport2024-03-012025-02-2814643092bus:FullAccounts2024-03-012025-02-2814643092bus:PrivateLimitedCompanyLtd2024-03-012025-02-2814643092core:WithinOneYear2025-02-2814643092core:AfterOneYear2025-02-2814643092core:WithinOneYear2024-02-2914643092core:AfterOneYear2024-02-2914643092core:ShareCapital2025-02-2814643092core:SharePremium2025-02-2814643092core:RevaluationReserve2025-02-2814643092core:OtherReservesSubtotal2025-02-2814643092core:RetainedEarningsAccumulatedLosses2025-02-2814643092core:ShareCapital2024-02-2914643092core:SharePremium2024-02-2914643092core:RevaluationReserve2024-02-2914643092core:OtherReservesSubtotal2024-02-2914643092core:RetainedEarningsAccumulatedLosses2024-02-2914643092core:LandBuildings2025-02-2814643092core:PlantMachinery2025-02-2814643092core:Vehicles2025-02-2814643092core:FurnitureFittings2025-02-2814643092core:OfficeEquipment2025-02-2814643092core:NetGoodwill2025-02-2814643092core:IntangibleAssetsOtherThanGoodwill2025-02-2814643092core:ListedExchangeTraded2025-02-2814643092core:UnlistedNon-exchangeTraded2025-02-2814643092core:LandBuildings2024-02-2914643092core:PlantMachinery2024-02-2914643092core:Vehicles2024-02-2914643092core:FurnitureFittings2024-02-2914643092core:OfficeEquipment2024-02-2914643092core:NetGoodwill2024-02-2914643092core:IntangibleAssetsOtherThanGoodwill2024-02-2914643092core:ListedExchangeTraded2024-02-2914643092core:UnlistedNon-exchangeTraded2024-02-2914643092core:LandBuildings2024-03-012025-02-2814643092core:PlantMachinery2024-03-012025-02-2814643092core:Vehicles2024-03-012025-02-2814643092core:FurnitureFittings2024-03-012025-02-2814643092core:OfficeEquipment2024-03-012025-02-2814643092core:NetGoodwill2024-03-012025-02-2814643092core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2814643092core:ListedExchangeTraded2024-03-012025-02-2814643092core:UnlistedNon-exchangeTraded2024-03-012025-02-2814643092core:MoreThanFiveYears2024-03-012025-02-2814643092core:Non-currentFinancialInstruments2025-02-2814643092core:Non-currentFinancialInstruments2024-02-2914643092dpl:CostSales2024-03-012025-02-2814643092dpl:DistributionCosts2024-03-012025-02-2814643092core:LandBuildings2024-03-012025-02-2814643092core:PlantMachinery2024-03-012025-02-2814643092core:Vehicles2024-03-012025-02-2814643092core:FurnitureFittings2024-03-012025-02-2814643092core:OfficeEquipment2024-03-012025-02-2814643092dpl:AdministrativeExpenses2024-03-012025-02-2814643092core:NetGoodwill2024-03-012025-02-2814643092core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2814643092dpl:GroupUndertakings2024-03-012025-02-2814643092dpl:ParticipatingInterests2024-03-012025-02-2814643092dpl:GroupUndertakingscore:ListedExchangeTraded2024-03-012025-02-2814643092core:ListedExchangeTraded2024-03-012025-02-2814643092dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-03-012025-02-2814643092core:UnlistedNon-exchangeTraded2024-03-012025-02-2814643092dpl:CostSales2023-02-062024-02-2914643092dpl:DistributionCosts2023-02-062024-02-2914643092core:LandBuildings2023-02-062024-02-2914643092core:PlantMachinery2023-02-062024-02-2914643092core:Vehicles2023-02-062024-02-2914643092core:FurnitureFittings2023-02-062024-02-2914643092core:OfficeEquipment2023-02-062024-02-2914643092dpl:AdministrativeExpenses2023-02-062024-02-2914643092core:NetGoodwill2023-02-062024-02-2914643092core:IntangibleAssetsOtherThanGoodwill2023-02-062024-02-2914643092dpl:GroupUndertakings2023-02-062024-02-2914643092dpl:ParticipatingInterests2023-02-062024-02-2914643092dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-062024-02-2914643092core:ListedExchangeTraded2023-02-062024-02-2914643092dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-062024-02-2914643092core:UnlistedNon-exchangeTraded2023-02-062024-02-2914643092core:NetGoodwill2025-02-2814643092core:IntangibleAssetsOtherThanGoodwill2025-02-2814643092core:LandBuildings2025-02-2814643092core:PlantMachinery2025-02-2814643092core:Vehicles2025-02-2814643092core:FurnitureFittings2025-02-2814643092core:OfficeEquipment2025-02-2814643092core:AfterOneYear2025-02-2814643092core:WithinOneYear2025-02-2814643092core:ListedExchangeTraded2025-02-2814643092core:UnlistedNon-exchangeTraded2025-02-2814643092core:ShareCapital2025-02-2814643092core:SharePremium2025-02-2814643092core:RevaluationReserve2025-02-2814643092core:OtherReservesSubtotal2025-02-2814643092core:RetainedEarningsAccumulatedLosses2025-02-2814643092core:NetGoodwill2024-02-2914643092core:IntangibleAssetsOtherThanGoodwill2024-02-2914643092core:LandBuildings2024-02-2914643092core:PlantMachinery2024-02-2914643092core:Vehicles2024-02-2914643092core:FurnitureFittings2024-02-2914643092core:OfficeEquipment2024-02-2914643092core:AfterOneYear2024-02-2914643092core:WithinOneYear2024-02-2914643092core:ListedExchangeTraded2024-02-2914643092core:UnlistedNon-exchangeTraded2024-02-2914643092core:ShareCapital2024-02-2914643092core:SharePremium2024-02-2914643092core:RevaluationReserve2024-02-2914643092core:OtherReservesSubtotal2024-02-2914643092core:RetainedEarningsAccumulatedLosses2024-02-2914643092core:NetGoodwill2023-02-0514643092core:IntangibleAssetsOtherThanGoodwill2023-02-0514643092core:LandBuildings2023-02-0514643092core:PlantMachinery2023-02-0514643092core:Vehicles2023-02-0514643092core:FurnitureFittings2023-02-0514643092core:OfficeEquipment2023-02-0514643092core:AfterOneYear2023-02-0514643092core:WithinOneYear2023-02-0514643092core:ListedExchangeTraded2023-02-0514643092core:UnlistedNon-exchangeTraded2023-02-0514643092core:ShareCapital2023-02-0514643092core:SharePremium2023-02-0514643092core:RevaluationReserve2023-02-0514643092core:OtherReservesSubtotal2023-02-0514643092core:RetainedEarningsAccumulatedLosses2023-02-0514643092core:AfterOneYear2024-03-012025-02-2814643092core:WithinOneYear2024-03-012025-02-2814643092core:Non-currentFinancialInstrumentscore:CostValuation2024-03-012025-02-2814643092core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-012025-02-2814643092core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-012025-02-2814643092core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-012025-02-2814643092core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-012025-02-2814643092core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-012025-02-2814643092core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2814643092core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2814643092core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2814643092core:Non-currentFinancialInstrumentscore:CostValuation2025-02-2814643092core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-2814643092core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-2814643092core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-2814643092core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-2814643092core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-2814643092core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-2814643092core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-2814643092core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-2814643092core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2914643092core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2914643092core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2914643092core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2914643092core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2914643092core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2914643092core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2914643092core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2914643092core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2914643092bus:Director12024-03-012025-02-28

DR KARINA LTD

Registered Number
14643092
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2025

DR KARINA LTD
Company Information
for the year from 1 March 2024 to 28 February 2025

Director

Dr Karina Vara

Registered Address

16 Woolerton Drive
Rothley
LE7 7UH

Registered Number

14643092 (England and Wales)
DR KARINA LTD
Statement of Financial Position
28 February 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3744930
744930
Current assets
Debtors5,8974,180
Cash at bank and on hand114,37537,447
120,27241,627
Creditors amounts falling due within one year4(21,863)(9,945)
Net current assets (liabilities)98,40931,682
Total assets less current liabilities99,15332,612
Net assets99,15332,612
Capital and reserves
Called up share capital11
Profit and loss account99,15232,611
Shareholders' funds99,15332,612
The financial statements were approved and authorised for issue by the Director on 27 August 2025, and are signed on its behalf by:
Dr Karina Vara
Director
Registered Company No. 14643092
DR KARINA LTD
Notes to the Financial Statements
for the year ended 28 February 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)
Office Equipment20
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 March 241,1631,163
At 28 February 251,1631,163
Depreciation and impairment
At 01 March 24233233
Charge for year186186
At 28 February 25419419
Net book value
At 28 February 25744744
At 29 February 24930930
4.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables-241
Taxation and social security19,3167,666
Other creditors78804
Accrued liabilities and deferred income2,4691,234
Total21,8639,945
5.Provisions for liabilities
6.Related party transactions
During the year the director loaned the company £78.22 (2024: £804). This loan is repayable upon demand. Interest was charged on the loan balance, on a monthly basis, at the UK market rate and has been accrued in the accounts.